These results validate the vaccine construct’s capacity to engage TLR3 and TLR4-mediated endosomal sensing pathways, initiating robust dendritic cell maturation and subsequent Th1-polarized adaptive immunity–critical features for eliciting durable antitumor responses in colorectal cancer. This evidence concerns the gene TLR4 and colorectal cancer.